Clinical Trial Update: Surufatinib Combined With Chemotherapy Plus Toripalimab or Not in the Treatment of Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Early-phase trial evaluating surufatinib with chemotherapy plus toripalimab (or without) in small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Surufatinib (Surufatinib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Small Cell Lung Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN